<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Extracorporeal life support in adults in the intensive care unit: Overview</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Extracorporeal life support in adults in the intensive care unit: Overview</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Extracorporeal life support in adults in the intensive care unit: Overview</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Darryl Abrams, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cara Agerstrand, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Justin Fried, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel Brodie, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott Manaker, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1738978487"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Extracorporeal membrane oxygenation (ECMO) is an advanced form of life support used mostly in patients with severe respiratory or cardiac failure when standard therapy fails. While in the past ECMO was associated with poor outcomes and high complication rates, technical advances coupled with accumulating data that describe successful outcomes [<a href="#rid1">1-4</a>] have resulted in a resurgence of ECMO use.</p><p>This topic will provide an overview of ECMO, including terminology and physiology and the selection of an appropriate ECMO configuration for patients with respiratory and/or cardiac failure. Other ECMO-relevant topics are found elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/127765.html" rel="external">"COVID-19: Extracorporeal membrane oxygenation (ECMO)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)"</a>.)</p><p></p><p class="headingAnchor" id="H2792463057"><span class="h1">TERMINOLOGY</span></p><p class="headingAnchor" id="H183631093"><span class="h2">Extracorporeal life support (ECLS)</span><span class="headingEndMark"> — </span>Extracorporeal life support (ECLS) encompasses a set of extracorporeal modalities that can provide oxygenation, carbon dioxide (CO<sub>2</sub>) removal, and/or circulatory support, excluding cardiopulmonary bypass for cardiothoracic or vascular surgery  (<a class="graphic graphic_table graphicRef140283" href="/z/d/graphic/140283.html" rel="external">table 1</a>) [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H37948482"><span class="h2">Extracorporeal membrane oxygenation (ECMO)</span><span class="headingEndMark"> — </span>Extracorporeal membrane oxygenation (ECMO) is a form of ECLS used for temporary support of patients with respiratory failure (for gas exchange) and/or cardiac failure (for cardiac support).</p><p>Venovenous ECMO (almost exclusively for respiratory failure) or venoarterial ECMO (for circulatory failure) are the two most common forms of ECMO used in the intensive care unit, although more complex configurations are sometimes needed.</p><p>Further details regarding configurations and indications for such configurations are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See <a class="local">'Drainage-reinfusion configurations'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Clinical applications'</a>.)</p><p></p><p class="headingAnchor" id="H2510948482"><span class="h2">Extracorporeal carbon dioxide removal (ECCO2R)</span><span class="headingEndMark"> — </span>Extracorporeal CO<sub>2</sub> removal (ECCO<sub>2</sub>R) is another form of ECLS, used for the sole purpose of CO<sub>2</sub> removal. It is not intended to impact the patient's oxygenation and typically provides only modest oxygenation at best. It provides no cardiac support. It is a common configuration used in patients with pure hypercapnic respiratory failure or patients with less severe forms of the acute respiratory distress syndrome who might benefit from increased lung-protective ventilatory strategies.</p><p></p><p>Configurations for ECCO<sub>2</sub>R are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See <a class="local">'Drainage-reinfusion configurations'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)", section on 'Clinical applications'</a>.)</p><p></p><p class="headingAnchor" id="H2873408049"><span class="h1">ECMO AND ECCO2R CIRCUITS</span><span class="headingEndMark"> — </span>An extracorporeal membrane oxygenation (ECMO) circuit pumps blood through an "artificial" or "membrane" lung, which performs the function of gas exchange (ie, oxygenation and carbon dioxide [CO<sub>2</sub>] removal). It can also be configured to provide circulatory support.</p><p class="headingAnchor" id="H1804268717"><span class="h2">Components</span><span class="headingEndMark"> — </span>In general, we prefer a simplified circuit consisting only of drainage and reinfusion cannulae, a pump, membrane lung, heat exchanger, oxygen source, blender, and connection tubing  (<a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef140678" href="/z/d/graphic/140678.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">figure 3</a>).</p><p>Occasionally, additional tubing (eg, Y-connectors) or additional cannulae (for enhanced drainage or reinfusion of blood) is required (eg, venoarteriovenous [V-AV] configuration  (<a class="graphic graphic_figure graphicRef140696" href="/z/d/graphic/140696.html" rel="external">figure 4</a>)).</p><p>The rationale for simple circuitry is to minimize turbulent blood flow that can promote thrombus formation and hemolysis and avoid sites of potential air entrainment, blood loss, or contamination.</p><p class="headingAnchor" id="H1064531866"><span class="h2">Drainage-reinfusion configurations</span><span class="headingEndMark"> — </span>ECMO/extracorporeal CO<sub>2</sub> removal (ECCO<sub>2</sub>R) circuits remove blood from a large, often central blood vessel or cardiac chamber (drainage cannula). That blood is pumped through a semipermeable membrane ("membrane lung"). The membrane lung directly oxygenates and removes CO<sub>2</sub>, and blood is returned to a large blood vessel or cardiac chamber (reinfusion cannula). Reinfused blood mixes with the native circulation to perfuse end-organs.</p><p>Configuration terminology describes the drainage and perfusion cannulae. Several configurations are available and comprehensive descriptions of them all is beyond the scope of this topic review. By convention, <strong>V</strong> denotes venous access, <strong>A</strong> denotes arterial access and the hyphen denotes where the membrane lung is in the circuit [<a href="#rid5">5</a>]. Common configurations include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venovenous (V-V) ECMO/ECCO</strong><strong><sub>2</sub></strong><strong>R configurations</strong> – The primary function of V-V ECMO is oxygenation and/or CO<sub>2</sub> removal. (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)"</a>.)</p><p></p><p class="bulletIndent1">In V-V circuits, blood is drained from a <strong>v</strong>ein or venous chamber (eg, central vein or right atrium), pumped through the membrane lung, and reinfused back into a <strong>v</strong>ein (sometimes the same vein/chamber as drainage component or a different vein or chamber). V-V ECMO relies on native cardiac function to circulate the reinfused blood. Examples are shown in the figures  (<a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef140678" href="/z/d/graphic/140678.html" rel="external">figure 2</a>).</p><p></p><p class="bulletIndent1">In V-V ECMO, the circuit can be implemented through the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Two anatomically separate sites using two separate cannulae (two-site configuration  (<a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">figure 1</a>))</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A single site using a cannula that has two lumens (ie, dual-lumen single-site configuration  (<a class="graphic graphic_figure graphicRef140678" href="/z/d/graphic/140678.html" rel="external">figure 2</a>))</p><p></p><p class="bulletIndent1">In two-site configurations, when the drainage and reinfusion cannulae are too close together, reinfused, oxygenated blood may be drawn into the drainage cannula and therefore back into the circuit without entering the systemic circulation ("recirculation"). This phenomenon is typically less common with dual-lumen single-site configurations. (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Troubleshooting circuit dysfunction'</a>.)</p><p></p><p class="bulletIndent1">For V-V ECCO<sub>2</sub>R, the circuit and configuration are similar to that described for V-V ECMO. However, compared with V-V ECMO, lower blood flow rates and smaller cannulae are typically used because CO<sub>2</sub> removal is more efficient than oxygenation. ECCO<sub>2</sub>R, when performed at low blood flow rates, generally provides little in the way of meaningful oxygenation. (See  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venoarterial (V-A) ECMO configurations</strong> – The primary function of V-A configurations is cardiac support while also providing gas exchange (when needed). (See  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)"</a>.)</p><p></p><p class="bulletIndent1">In V-A circuits, blood is drained from a central <strong>v</strong>ein, pumped through the membrane lung, and reinfused into an <strong>a</strong>rtery (most commonly the femoral artery), thereby providing both gas exchange and circulatory support. An example is shown in the figure  (<a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">figure 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hybrid ECMO configurations</strong> – Some circuits have two reinfusion cannulae (one into a vein and one into an artery), effectively providing both venovenous and venoarterial support, referred to as a hybrid configuration. In general, the terminology is specific for what the patient started with and what was added. For example, patients receiving V-V ECMO may have an <strong>a</strong>rterial reinfusion cannula placed when additional cardiac support is needed (venovenoarterial [V-V<strong>A</strong>]); patients on V-A ECMO may need a <strong>v</strong>enous reinfusion cannula placed when additional respiratory support is needed (venoarteriovenous [V-A<strong>V</strong>]). In most situations, a second reinfusion cannula is added to an existing circuit, although some patients may require a hybrid configuration from the outset in the setting of concomitant severe respiratory and cardiac failure. An example is shown in the graphic  (<a class="graphic graphic_figure graphicRef140696" href="/z/d/graphic/140696.html" rel="external">figure 4</a>). (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Managing concomitant cardiac failure'</a> and  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Concomitant respiratory failure'</a>.)</p><p></p><p class="bulletIndent1">While a hybrid configuration is defined by additional <strong>reinfusion</strong> cannulae, it does not refer to the addition of a second <strong>drainage</strong> cannula. For example, in circumstances where blood flow is limited by excess negative drainage pressure, a second drainage cannula may be appropriate (eg, venovenovenous [<strong>V</strong>V-V] or venovenoarteriovenous [<strong>V</strong>V-AV]).</p><p></p><p>Less common configurations include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pumpless arteriovenous (A-V) ECLS configurations</strong> – The primary functions of A-V configurations include ECCO<sub>2</sub>R (eg, femoral artery-to-femoral-vein configuration) and "off-loading" of the right ventricle (pulmonary artery-to-left atrium configuration) [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">Pumpless A-V ECLS is a far less common, low-flow arteriovenous cannulation strategy, relying on native cardiac output rather than an external pump to generate extracorporeal blood flow, which will be more limited in flow when compared with extracorporeal blood flow generated by a centrifugal pump [<a href="#rid7">7</a>]. Drainage and reinfusion cannulae are most commonly located in the femoral artery and femoral vein, respectively, with the membrane lung in between, which provides A-V ECCO<sub>2</sub>R. In select patients with pulmonary hypertension awaiting lung transplantation, a comparable pumpless arteriovenous configuration may be applied, wherein blood is pumped by the right ventricle from the pulmonary artery, through the membrane lung, and returned to the pulmonary vein or left atrium, thereby offloading the right ventricle and providing an oxygenated right-to-left shunt.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venous-to-pulmonary artery (V-PA) ECMO configurations</strong> – An alternative configuration for V-V ECMO is a V-PA configuration. It may also serve as an alternative to V-A ECMO for isolated acute right ventricular failure.</p><p></p><p class="bulletIndent1">This configuration drains blood from the right atrium, pumps it through the membrane lung, and returns it to the pulmonary artery either through the second lumen of a dual-lumen cannula or using a two-site set up. An example is shown in the graphic  (<a class="graphic graphic_diagnosticimage graphicRef128291" href="/z/d/graphic/128291.html" rel="external">image 1</a> and <a class="graphic graphic_figure graphicRef140683" href="/z/d/graphic/140683.html" rel="external">figure 5</a>). Challenges with placement and maintenance of proper positioning, along with cost, may make this approach less desirable than the traditional two-site V-V ECMO for the majority of patients.</p><p></p><p class="headingAnchor" id="H4224611882"><span class="h1">DETERMINANTS OF GAS EXCHANGE</span><span class="headingEndMark"> — </span>The table lists the major determinants of oxygenation and carbon dioxide (CO<sub>2</sub>) removal  (<a class="graphic graphic_table graphicRef140684" href="/z/d/graphic/140684.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H106008202"><span class="h2">Oxygenation</span></p><p class="headingAnchor" id="H595441724"><span class="h3">ECMO blood flow rate</span><span class="headingEndMark"> — </span>The degree of oxygenation derived from the circuit is largely determined by the extracorporeal membrane oxygenation (ECMO) blood flow rate (ie, the rate at which blood enters the membrane), which is most often manually set (typically 3 to 7 L/minute) [<a href="#rid8">8</a>]. Most of the time, blood exiting the membrane lung is 100 percent saturated with oxygen, provided the membrane is functioning properly.</p><p class="headingAnchor" id="H203529299"><span class="h3">ECMO blood flow rate relative to native cardiac output (V-V ECMO)</span><span class="headingEndMark"> — </span>In venovenous (V-V) ECMO, <strong>systemic</strong> oxygenation is largely determined by the contribution of V-V ECMO-derived oxygenated blood relative to the overall circulating blood volume (ie, the proportion of blood flowing through the ECMO circuit relative to native cardiac output), along with the contribution from native lung function.</p><p class="bulletIndent1"><span class="glyph">●</span>When the ECMO blood flow rate is high (eg, 4 L/minute) relative to the native cardiac output (eg, 5 L/minute; 80 percent of cardiac output going through the membrane lung), then most of the systemic oxygenation is derived from the ECMO circuit.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the ECMO blood flow rate is low (eg, 2 L/minute) relative to the native cardiac output (eg, 5 L/minute; 40 percent of cardiac output going through the membrane lung), then the contribution of ECMO-derived oxygenation is lower.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the ECMO blood flow rate is steady (eg, 4 L/minute) but native cardiac output changes (eg, increase from 5 to 10 L/minute in the setting of vasodilatory shock), then the contribution of ECMO-derived oxygenation will decrease (from 80 to 40 percent of cardiac output going through the membrane lung), resulting in decreased systemic oxygenation.</p><p></p><p class="bulletIndent1">A clinical study of V-V ECMO patients demonstrated that a ratio of ECMO blood flow to cardiac output &gt;60 percent consistently resulted in systemic arterial oxygen saturation &gt;90 percent [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H3914173245"><span class="h3">Dual circulation (V-A ECMO)</span><span class="headingEndMark"> — </span>In venoarterial (V-A) ECMO, a phenomenon known as dual circulation may also affect regional differences in oxygen delivery [<a href="#rid1">1</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>During femoral V-A ECMO, when left ventricular (LV) output is minimal or absent, the reinfused extracorporeal blood flows retrograde up the aorta and across the aortic arch, perfusing the entire body including the cerebral and coronary vascular beds. However, in the presence of native LV ejection, a <strong>mixing point</strong> will develop between the reinfused blood from the ECMO circuit and that from the native cardiac output. The mixing point is dynamic depending upon the relative strengths of the native and extracorporeal pumps, a phenomenon known as <strong>competitive flow</strong>. If the mixing point occurs in the descending aorta, then upper body oxygenation will be supplied by native cardiac output while the lower body is supplied by the ECMO circuit, effectively establishing <strong>dual circulations</strong>. If the native cardiac output ejects poorly oxygenated blood (eg, in the setting of concomitant cardiogenic pulmonary edema or underlying lung injury), then the upper body and, most importantly, the coronary and cerebral circulations, may be inadequately oxygenated while the lower body is well-oxygenated, referred to as <strong>differential oxygenation</strong>. Differential CO<sub>2</sub> tension may likewise occur as a consequence of dual circulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Axillary, subclavian, and innominate artery reinfusion circuits may have relatively less differential oxygenation due to the reinfused blood being delivered close to the aortic arch. In antegrade proximal aortic reinfusion, there is minimal if any differential oxygenation due to anterograde flow from the aortic root, and in left atrial reinfusion, there is no differential oxygenation.</p><p></p><p>Complications that can develop from dual circulation and competitive flow are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'V-A ECMO-specific complications'</a>.)</p><p class="headingAnchor" id="H850375628"><span class="h3">Others</span><span class="headingEndMark"> — </span>Other determinants of oxygenation include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Diffusion properties of the membrane lung (eg, properties intrinsic to the material itself or the presence of thrombus).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Membrane surface area and design.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The degree of recirculation (ie, blood recirculating back to the reinfusion port; applies to V-V ECMO only). (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Troubleshooting circuit dysfunction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Native lung gas exchange.</p><p></p><p class="headingAnchor" id="H1802103571"><span class="h2">Carbon dioxide removal</span><span class="headingEndMark"> — </span>The degree of CO<sub>2</sub> removal by the circuit is largely determined by the sweep gas flow rate at high blood flow rates and by both sweep gas and blood flow rates at lower blood flow rates. Sweep gas is a controlled blend of oxygen and air that passes through the membrane lung; the fraction of oxygen that is delivered to the membrane lung is referred to as the fraction of delivered oxygen (FDO<sub>2</sub>). The FDO<sub>2</sub> should be distinguished from the fraction of oxygen inspired into the lungs (ie, oxygen delivered via mechanical ventilation to the native lung). FDO<sub>2</sub> is typically set at 100 percent unless a patient is undergoing weaning from ECMO or is hyperoxemic.</p><p>Membrane lung surface area and the partial pressure of CO<sub>2</sub> entering the membrane are also major determinants of CO<sub>2</sub> removal.</p><p>Other determinants include diffusion properties of the membrane lung and native gas exchange.</p><p>CO<sub>2</sub> removal is more efficient than oxygenation owing to diffusion properties of CO<sub>2</sub> and the ability to maintain a large gradient across the membrane through increases in the sweep gas flow rate. Thus, extracorporeal CO<sub>2</sub> removal (ECCO<sub>2</sub>R) may be used in most circumstances at lower blood flow rates and through smaller cannulae than what is usually required for oxygenation during V-V or V-A ECMO, although blood flow rate itself does not define ECCO<sub>2</sub>R. (See  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)"</a>.)</p><p class="headingAnchor" id="H1879588818"><span class="h1">INITIAL PATIENT SELECTION FOR SPECIFIC ECLS MODE</span><span class="headingEndMark"> — </span>The approach outlined in the sections below is considered a high-level, broad, overview of ECLS mode selection.</p><p class="bulletIndent1"><span class="glyph">●</span>Selecting an appropriate mode of ECLS is largely dependent upon the organ failure that needs supporting and the pattern of gas exchange that needs to be corrected. (See <a class="local">'Type of support needed'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Once selected, individual patient-related factors influence the decision to proceed with ECLS (eg, comorbidities, underlying lung or cardiac disease) and the technical factors surrounding implementation. (See <a class="local">'Patient-specific factors'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The process is a <strong>team-directed</strong> approach. (See <a class="local">'Staffing (ECMO teams)'</a> below.)</p><p></p><p>Guidelines that describe the indications and practice of ECLS are published by the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.elso.org%2F&amp;token=NyRkA1K%2BEfcjom0B%2BqrukvFcezSIP8grIF6J6FVMBCQ%3D&amp;TOPIC_ID=1625" target="_blank">Extracorporeal Life Support Organization (ELSO)</a> [<a href="#rid9">9,10</a>].</p><p>In general, supportive data for the practice of extracorporeal membrane oxygenation (ECMO) are lacking and mostly derived from observational case series with the exception of acute hypoxemic respiratory failure due to the acute respiratory distress syndrome (ARDS). (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Clinical applications'</a> and  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)", section on 'Clinical applications'</a> and  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Clinical applications'</a>.)</p><p class="headingAnchor" id="H3292379556"><span class="h2">Type of support needed</span></p><p class="headingAnchor" id="H3313655923"><span class="h3">Patients who need respiratory support and oxygenation (V-V ECMO)</span><span class="headingEndMark"> — </span>We evaluate patients who primarily have hypoxemic or hypercapnic respiratory failure as potential candidates for venovenous (V-V) ECMO. The goals of V-V ECMO under these circumstances are to support oxygenation and manage carbon dioxide (CO<sub>2</sub>) removal to facilitate lung-protective ventilation. Further details regarding the implementation of V-V ECMO are provided separately. (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)"</a>.)</p><p class="headingAnchor" id="H2105758929"><span class="h3">Patients who need cardiac/circulatory support (V-A ECMO)</span><span class="headingEndMark"> — </span>We evaluate patients who primarily have cardiac/circulatory failure as potential candidates for venoarterial (V-A) ECMO; this includes patients with left-sided heart failure and/or right-sided heart failure (eg, from right ventricular infarction, massive pulmonary embolism, or pulmonary hypertension), patients with refractory shock due to other conditions, including trauma, anaphylaxis, drowning, organ donation, poisoning  (<a class="graphic graphic_table graphicRef140779" href="/z/d/graphic/140779.html" rel="external">table 3</a>), and hypothermia, and patients who need support during cardiopulmonary resuscitation. The goal of V-A ECMO under those circumstances is circulatory support, but patients may also derive benefit from extracorporeal oxygenation and CO<sub>2</sub> removal if needed. Further details regarding the implementation of V-A ECMO are provided separately. (See  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)"</a>.)</p><p class="headingAnchor" id="H2983802015"><span class="h3">Patients with pure hypercapnic respiratory failure who only need carbon dioxide removal (V-V ECCO2R)</span><span class="headingEndMark"> — </span>We evaluate patients who have predominantly hypercapnic respiratory failure as potential candidates for V-V extracorporeal CO<sub>2</sub> removal (ECCO<sub>2</sub>R). The goal of V-V ECCO<sub>2</sub>R under those circumstances is CO<sub>2</sub> removal. Oxygenation support is minimal. Further details regarding the implementation of ECCO<sub>2</sub>R are provided separately. (See  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)"</a>.)</p><p class="headingAnchor" id="H1409816595"><span class="h2">Patient-specific factors</span></p><p class="headingAnchor" id="H2982029293"><span class="h3">ECLS as a bridge to an endpoint</span><span class="headingEndMark"> — </span>During the evaluation for ECLS, we assess patients for their suitability for advanced life support therapies in general. One of the most important aspects of the decision to proceed with ECLS is whether it will provide any of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>A bridge to recovery (ie, is the disease potentially reversible?).</p><p class="bulletIndent1"><span class="glyph">●</span>A bridge to receiving an additional life-saving intervention, such as lung or heart transplant, a ventricular assist device, total artificial heart, thoracic or airway surgical procedure, coronary artery stenting, or bypass grafting.</p><p class="bulletIndent1"><span class="glyph">●</span>A bridge to decision (eg, organ transplant).</p><p></p><p>In general, most experts would not consider ECLS as appropriate for patients in whom such endpoints are not achievable (ie, ECLS as a "bridge-to-nowhere").</p><p>This can be a difficult assessment in an acute setting when the details required for such a prediction may be unknown or missing and the process may be fraught with ethical dilemmas. When recovery or device/transplant candidacy is uncertain, we use the term "bridge to decision." This is most commonly encountered for ECLS in cardiac failure; in such cases, recovery, transplantation, and destination device therapy are all potential options, but candidacy for a given endpoint is often uncertain until there is clarity on the likelihood of both cardiac and extra-cardiac organ recovery.</p><p>However, the use of ECLS as "bridge to decision" may create a greater opportunity for a "bridge-to-nowhere," especially in the setting of end-stage lung disease where determination that the patient is not a candidate for transplantation leaves few other options. In that context, we only use ECLS as a bridge to lung transplantation for patients who have already been deemed appropriate candidates for transplantation [<a href="#rid11">11,12</a>]. In exceptional circumstances, ECLS may be considered in patients not previously evaluated for transplantation if patient characteristics suggest both feasibility of transplant evaluation and a high likelihood of candidacy for transplantation once receiving ECMO [<a href="#rid13">13</a>]. The International Society of Heart and Lung Transplantation highlights younger age, absence of multiorgan dysfunction, and good rehabilitation potential as patient characteristics for which ECLS is suitable for bridging to lung transplantation [<a href="#rid14">14</a>]. Recommendations against ECMO for bridge to transplant include septic shock, multiorgan dysfunction, severe arterial occlusive disease, heparin-induced thrombocytopenia, prior prolonged mechanical ventilation, advanced age, and obesity. (See  <a class="medical medical_review" href="/z/d/html/4658.html" rel="external">"Lung transplantation: General guidelines for recipient selection"</a>.)</p><p>Ethical dilemmas exist when making the decision to proceed with ECLS; such discussions are beyond the scope of this review. [<a href="#rid15">15-18</a>].</p><p class="headingAnchor" id="H1939323587"><span class="h3">Technical factors of implementation</span><span class="headingEndMark"> — </span>Once it is decided that ECLS is appropriate, we then assess patients for their suitability for the selected mode (eg, V-V ECMO, V-A ECMO, venoarteriovenous ECMO). This assessment is provided separately. (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Initial clinical assessment'</a> and  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Initial clinical assessment'</a>.)</p><p class="headingAnchor" id="H1074938531"><span class="h2">Staffing (ECMO teams)</span><span class="headingEndMark"> — </span>ECLS should <strong>only</strong> be administered in institutions that have a trained team qualified to perform ECLS care. We obtain input from an interprofessional team of healthcare providers as well as the patient or family members or surrogate decision-makers to make an informed decision to proceed or not proceed with ECLS.</p><p>Teams include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>A primary team responsible for the overall care of the patient in the intensive care unit – This typically consists of attendings (eg, intensivist, surgeon, cardiologist), fellows, residents, advanced practice providers, registered nurses, respiratory therapists, physical and occupational therapists, speech and language therapists, nutritionists, social workers, pastoral care, and psychologists.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Individuals performing cannulation – This varies by institution and may include cardiothoracic or vascular surgeons, interventional cardiologists, anesthesiologists, intensivists, or emergency medicine physicians.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Individuals responsible for circuit monitoring, management, and troubleshooting – These are often referred to as "ECLS/ECMO specialists," vary by institution, and may include perfusionists, nurses, respiratory therapists, physicians, or other clinicians.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other specialists – Beyond cannulation and circuit management, a broad range of disciplines is often involved in the care of this critically ill population (eg, infectious diseases, hematology, and neurology consultants).</p><p></p><p>We encourage the development of referral networks in which hospitals with less ECLS/ECMO experience and limited resources develop relationships with high-volume ECMO centers capable of providing all such therapies. This opinion is based upon the positive correlation between ECLS/ECMO center case volume and outcomes [<a href="#rid19">19</a>], the high resource intensity of ECLS, and the frequent need for other concomitant advanced therapies in this patient population (eg, prone positioning, lung or heart transplantation, cardiac catheterization, or other forms of temporary and durable mechanical circulatory support). [<a href="#rid20">20,21</a>]. These relationships should have mutually agreed-upon indications and contraindications for ECMO and may involve cannulation by either the originating or the receiving center. The latter arrangement also requires the ability to safely perform interfacility transport with ECMO support [<a href="#rid22">22-25</a>].</p><p>Interdisciplinary and interprofessional collaboration, with clearly defined roles and responsibilities, is vital to a successful ECLS program [<a href="#rid20">20,21</a>]. An education curriculum with initial and ongoing ECMO role-specific training, including simulation training, should be provided to all members of the program.</p><p class="headingAnchor" id="H1787073477"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>The complications of ECLS (extracorporeal membrane oxygenation [ECMO], extracorporeal carbon dioxide removal) are listed in the table  (<a class="graphic graphic_table graphicRef140676" href="/z/d/graphic/140676.html" rel="external">table 4</a>). Common complications, regardless of venovenous or venoarterial configuration, include the following [<a href="#rid26">26,27</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Hemorrhage (cannula-related, surgical site, other sites, such as gastrointestinal or retroperitoneal)</p><p class="bulletIndent1"><span class="glyph">●</span>Thrombosis (circuit-related, cannulae-related, arterial or venous thromboembolism)</p><p class="bulletIndent1"><span class="glyph">●</span>Infection (eg, surgical site, systemic)</p><p class="bulletIndent1"><span class="glyph">●</span>Hemolysis</p><p class="bulletIndent1"><span class="glyph">●</span>Thrombocytopenia, including heparin-induced thrombocytopenia</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac or vascular perforation during cannulation</p><p></p><p>These and other complications specific to ECMO configuration or mode are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'V-A ECMO-specific complications'</a>.)</p><p class="headingAnchor" id="H626583400"><span class="h1">PROGNOSIS AND LONG-TERM OUTCOMES</span></p><p class="headingAnchor" id="H4258298664"><span class="h2">Prognosis and prognostic scores</span><span class="headingEndMark"> — </span>Survival in patients who receive ECLS can be expected to vary by indication for extracorporeal membrane oxygenation (ECMO) or extracorporeal carbon dioxide removal (ECCO<sub>2</sub>R), complications that occur, and patient-related factors (eg, underlying comorbidities) [<a href="#rid3">3,4,28-35</a>]. For example, patients who receive venoarterial (V-A) ECMO for cardiac arrest (referred to as extracorporeal cardiopulmonary resuscitation) might be expected to have a worse outcome than those who receive V-A ECMO for sepsis-related cardiogenic shock. Retrospective data suggest that repeat ECMO after failing decannulation and hematopoietic stem cell transplantation are associated with poor outcomes [<a href="#rid36">36,37</a>].</p><p>Several scoring systems have been derived to help prognosticate survival of patients being considered for ECLS for both respiratory and cardiac failure [<a href="#rid31">31,38-42</a>]. These prognostic scores all have limitations in their clinical applications and are used variably in clinical practice.</p><p>Specific outcomes are discussed separately under the relevant indications.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Clinical applications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Clinical applications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)", section on 'Clinical applications'</a>.)</p><p></p><p class="headingAnchor" id="H2048639246"><span class="h2">Sequalae</span><span class="headingEndMark"> — </span>Among those who recover from ECMO support, many experience physical, psychological, and neurocognitive dysfunction, similar to that experienced by survivors of critical illness (also known as "post-intensive care unit syndrome" [PICS]) and survivors of the acute respiratory distress syndrome. Details regarding PICS are provided separately. (See  <a class="medical medical_review" href="/z/d/html/1601.html" rel="external">"Acute respiratory distress syndrome: Prognosis and outcomes in adults", section on 'Morbidity among survivors'</a> and  <a class="medical medical_review" href="/z/d/html/88330.html" rel="external">"Post-intensive care syndrome (PICS) in adults: Clinical features and diagnostic evaluation"</a>.)</p><p>Data to support components of PICS in survivors of ECLS include the following [<a href="#rid43">43-47</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In a large retrospective Canadian study of 642 survivors of ECMO, the incidence of new mental health conditions was 22 per 100 person-years compared with 14.5 per 100 person-years in 3820 matched intensive care unit survivors who did not receive ECMO [<a href="#rid47">47</a>]. These conditions mostly included mood disorders, anxiety, and posttraumatic stress disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In an Australian cohort of 442 ECMO survivors, death or moderate-to-severe disability at six months was reported in two thirds of survivors and only one third were alive without moderate disability [<a href="#rid48">48</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Data comparing outcomes with those who have undergone mechanical ventilation only are conflicting. A meta-analysis of ECMO survivors (for ARDS) suggested worse health-related quality of life but less psychological morbidity compared with ARDS patients supported with conventional mechanical ventilation alone [<a href="#rid43">43</a>]. One small retrospective case series of patients who received venovenous ECMO for acute respiratory failure reported no differences in cognitive or sleep outcomes at 6 and 12 months compared with patients who were managed with mechanical ventilation alone [<a href="#rid44">44</a>].</p><p></p><p class="headingAnchor" id="H903110240"><span class="h1">FUTURE RESEARCH AND RESOURCES</span><span class="headingEndMark"> — </span>Future trials will help to identify patients most likely to benefit from ECLS, including extracorporeal membrane oxygenation (ECMO) facilitated cardiopulmonary resuscitation (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03813134&amp;token=nbsXe3i4qfUea5RCPRHtOS7yhoEzH%2BMCpwZ1%2F1ekxPMhc9TdZy2SG5FK%2BkjeRrdP7atTdG5vALJaU5o493XhNw%3D%3D&amp;TOPIC_ID=1625" target="_blank">NCT03813134</a>) [<a href="#rid49">49</a>].</p><p>National and international ECMO organizations help facilitate collaboration across centers in the performance of trials.</p><p class="bulletIndent1"><span class="glyph">●</span>The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.elso.org%2F&amp;token=NyRkA1K%2BEfcjom0B%2BqrukvFcezSIP8grIF6J6FVMBCQ%3D&amp;TOPIC_ID=1625" target="_blank">Extracorporeal Life Support Organization (ELSO)</a> maintains the largest registry of ECMO patients, which has proven to be a valuable tool both for research and quality benchmarking [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The International ECMO Network (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.internationalecmonetwork.org%2F&amp;token=bJ98wEjwYbR6KcGnbD%2BLobdbJxu0rGwyQSkLHjo8Q%2BBdGrGt3TaM0X%2BxKeZEa54wXutnlX%2FuOo%2B%2FJJs1e%2BUQnA%3D%3D&amp;TOPIC_ID=1625" target="_blank">ECMONet</a>) is a research consortium that includes ECMO-specific expertise dedicated to conducting and supporting high-quality, high-impact research in the field [<a href="#rid51">51</a>].</p><p></p><p class="headingAnchor" id="H1460917388"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/134964.html" rel="external">"Patient education: Extracorporeal membrane oxygenation (ECMO) (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H1874493238"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – Extracorporeal life support (ECLS) encompasses a set of extracorporeal modalities that can provide oxygenation, carbon dioxide (CO<sub>2</sub>) removal, and/or circulatory support  (<a class="graphic graphic_table graphicRef140283" href="/z/d/graphic/140283.html" rel="external">table 1</a>). (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Venovenous (V-V) extracorporeal membrane oxygenation (ECMO) and venoarterial (V-A) ECMO are the two most common forms of ECMO used in the intensive care unit. V-V ECMO is used for the temporary support of patients with respiratory failure (for gas exchange), and V-A ECMO is used to support patients with cardiac failure (for circulatory support).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Extracorporeal CO<sub>2</sub> removal (ECCO<sub>2</sub>R) is another uncommon form of ECLS, used for the sole purpose of CO<sub>2</sub> removal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Circuits and configurations</strong> – An ECMO circuit pumps blood through an "artificial" or "membrane" lung that performs the functions of gas exchange (ie, oxygenation and CO<sub>2</sub> removal) and/or circulatory support  (<a class="graphic graphic_table graphicRef140684" href="/z/d/graphic/140684.html" rel="external">table 2</a>). (See <a class="local">'ECMO and ECCO2R circuits'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Circuits typically consist of drainage and reinfusion cannulae, a pump, membrane lung, heat exchanger, oxygen source, blender, and connection tubing  (<a class="graphic graphic_figure graphicRef140301" href="/z/d/graphic/140301.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef140678" href="/z/d/graphic/140678.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef140295" href="/z/d/graphic/140295.html" rel="external">figure 3</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Occasionally, additional tubing (eg, Y-connectors) or additional cannulae (for enhanced drainage or reinfusion of blood) is required (eg, venoarterio<strong>v</strong>enous [V-A<strong>V</strong>] configuration  (<a class="graphic graphic_figure graphicRef140696" href="/z/d/graphic/140696.html" rel="external">figure 4</a>)).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial ECLS mode selection</strong> – Selecting an appropriate mode of ECLS is largely dependent upon the organ failure that needs supporting and the pattern of gas exchange that needs to be corrected. (See <a class="local">'Type of support needed'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Primary respiratory failure</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients who primarily have hypoxemic or hypercapnic respiratory failure are potential candidates for V-V ECMO. (See <a class="local">'Patients who need respiratory support and oxygenation (V-V ECMO)'</a> above and  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients who have predominantly hypercapnic respiratory failure and do not need oxygenation support are potential candidates for V-V ECCO<sub>2</sub>R. (See <a class="local">'Patients with pure hypercapnic respiratory failure who only need carbon dioxide removal (V-V ECCO2R)'</a> above and  <a class="medical medical_review" href="/z/d/html/134496.html" rel="external">"Extracorporeal life support in adults: Extracorporeal carbon dioxide removal (ECCO2R)"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who primarily have cardiac failure, including right-sided heart failure (eg, from right ventricular infarction, massive pulmonary embolism or pulmonary hypertension), are potential candidates for V-A ECMO. (See <a class="local">'Patients who need cardiac/circulatory support (V-A ECMO)'</a> above and  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multidisciplinary approach</strong> – Individual patient-related factors influence the decision to proceed with ECLS (eg, comorbidities, underlying lung or cardiac disease, technical factors). The process is a <strong>team-directed</strong> approach ensuring a bridge to recovery, intervention, or a decision. (See <a class="local">'Patient-specific factors'</a> above and <a class="local">'Staffing (ECMO teams)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – Complications are listed in the table  (<a class="graphic graphic_table graphicRef140676" href="/z/d/graphic/140676.html" rel="external">table 4</a>), among which hemorrhage, thrombosis, hemolysis, thrombocytopenia, and infection are the most common. (See  <a class="medical medical_review" href="/z/d/html/134266.html" rel="external">"Extracorporeal life support in adults: Management of venovenous extracorporeal membrane oxygenation (V-V ECMO)", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'V-A ECMO-specific complications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – Survival in patients who receive ECLS can be expected to vary by indication, complications that occur, and patient-related factors (eg, underlying comorbidities).</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Brodie D, Slutsky AS, Combes A. Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review. JAMA 2019; 322:557.</a></li><li><a class="nounderline abstract_t">Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374:1351.</a></li><li><a class="nounderline abstract_t">Combes A, Hajage D, Capellier G, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med 2018; 378:1965.</a></li><li><a class="nounderline abstract_t">Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet 2020; 396:1807.</a></li><li><a class="nounderline abstract_t">Conrad SA, Broman LM, Taccone FS, et al. The Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support. A Position Paper of the Extracorporeal Life Support Organization. Am J Respir Crit Care Med 2018; 198:447.</a></li><li><a class="nounderline abstract_t">Strueber M, Hoeper MM, Fischer S, et al. Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant 2009; 9:853.</a></li><li><a class="nounderline abstract_t">Conrad SA, Zwischenberger JB, Grier LR, et al. Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study. Intensive Care Med 2001; 27:1340.</a></li><li><a class="nounderline abstract_t">Schmidt M, Tachon G, Devilliers C, et al. Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Med 2013; 39:838.</a></li><li class="breakAll">https://www.elso.org/Portals/0/ELSO%20Guidelines%20General%20All%20ECLS%20Version%201_4.pdf (Accessed on July 23, 2018).</li><li><a class="nounderline abstract_t">Tsai HC, Chang CH, Tsai FC, et al. Acute Respiratory Distress Syndrome With and Without Extracorporeal Membrane Oxygenation: A Score Matched Study. Ann Thorac Surg 2015; 100:458.</a></li><li><a class="nounderline abstract_t">Warren WA, Walter RJ, Mason PE. COUNTERPOINT: Should Patients With Advanced Lung Disease Be Offered Extracorporeal Membrane Oxygenation as a Bridge to Transplant If They Have Not Yet Been Listed for Lung Transplant? No. Chest 2020; 158:38.</a></li><li><a class="nounderline abstract_t">Abrams D, Brodie D, Arcasoy SM. Extracorporeal Life Support in Lung Transplantation. Clin Chest Med 2017; 38:655.</a></li><li><a class="nounderline abstract_t">Gannon WD, Stokes JW, Bacchetta M. POINT: Should Patients With Advanced Lung Disease Be Offered Extracorporeal Membrane Oxygenation as a Bridge to Transplant If They Have Not Yet Been Listed for Lung Transplant? Yes. Chest 2020; 158:35.</a></li><li><a class="nounderline abstract_t">Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015; 34:1.</a></li><li><a class="nounderline abstract_t">Abrams DC, Prager K, Blinderman CD, et al. Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest 2014; 145:876.</a></li><li><a class="nounderline abstract_t">Abrams D, Curtis JR, Prager KM, et al. Ethical Considerations for Mechanical Support. Anesthesiol Clin 2019; 37:661.</a></li><li><a class="nounderline abstract_t">Supady A, Curtis JR, Abrams D, et al. Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks. Lancet Respir Med 2021; 9:430.</a></li><li><a class="nounderline abstract_t">Abrams D, Lorusso R, Vincent JL, Brodie D. ECMO during the COVID-19 pandemic: when is it unjustified? Crit Care 2020; 24:507.</a></li><li><a class="nounderline abstract_t">Barbaro RP, Odetola FO, Kidwell KM, et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 2015; 191:894.</a></li><li><a class="nounderline abstract_t">Abrams D, Garan AR, Abdelbary A, et al. Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med 2018; 44:717.</a></li><li><a class="nounderline abstract_t">Combes A, Brodie D, Bartlett R, et al. Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 2014; 190:488.</a></li><li><a class="nounderline abstract_t">Tipograf Y, Liou P, Oommen R, et al. A decade of interfacility extracorporeal membrane oxygenation transport. J Thorac Cardiovasc Surg 2019; 157:1696.</a></li><li><a class="nounderline abstract_t">Broman LM, Holzgraefe B, Palmér K, Frenckner B. The Stockholm experience: interhospital transports on extracorporeal membrane oxygenation. Crit Care 2015; 19:278.</a></li><li><a class="nounderline abstract_t">Bryner B, Cooley E, Copenhaver W, et al. Two decades' experience with interfacility transport on extracorporeal membrane oxygenation. Ann Thorac Surg 2014; 98:1363.</a></li><li class="breakAll">Brechot N, Mastroianni C, Schmidt M, et al. Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: Any impact on their outcomes? J Thorac Cardiovasc Surg 2018; 155:e1621.</li><li><a class="nounderline abstract_t">Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J 2017; 63:60.</a></li><li class="breakAll">International Summary of the ECMO Registry of the Extracorporeal Life Support Organization (ELSO), Ann Arbor, Michigan, July 2019. Available at: www.elso.org/Registry/Statistics/InternationalSummary.aspx. Accessed 19 June, 2021.</li><li><a class="nounderline abstract_t">Bréchot N, Hajage D, Kimmoun A, et al. Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study. Lancet 2020; 396:545.</a></li><li class="breakAll">ECLS International Summary of Statistics. https://elso.org/Registry/InternationalSummaryandReports/InternationalSummary.aspx (Accessed on May 18, 2022).</li><li><a class="nounderline abstract_t">Belohlavek J, Smalcova J, Rob D, et al. Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA 2022; 327:737.</a></li><li><a class="nounderline abstract_t">Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 2015; 36:2246.</a></li><li><a class="nounderline abstract_t">Steimer DA, Hernandez O, Mason DP, Schwartz GS. Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDS. Thorac Cardiovasc Surg 2019; 67:212.</a></li><li><a class="nounderline abstract_t">Hu RTC, Broad JD, Osawa EA, et al. 30-Day Outcomes Post Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO) After Cardiac Surgery and Predictors of Survival. Heart Lung Circ 2020; 29:1217.</a></li><li><a class="nounderline abstract_t">Marinacci LX, Mihatov N, D'Alessandro DA, et al. Extracorporeal cardiopulmonary resuscitation (ECPR) survival: A quaternary center analysis. J Card Surg 2021; 36:2300.</a></li><li class="breakAll">ECLS Registry Report. Extracorporeal Life Support Organization. April, 2023. Available at: https://www.elso.org/Registry/InternationalSummaryandReports/InternationalSummary.aspx (Accessed on June 06, 2022).</li><li><a class="nounderline abstract_t">Cooper DS, Thiagarajan R, Henry BM, et al. Outcomes of Multiple Runs of Extracorporeal Membrane Oxygenation: An analysis of the Extracorporeal Life Support Registry. J Intensive Care Med 2022; 37:195.</a></li><li><a class="nounderline abstract_t">Pravin RR, Huang BX, Sultana R, et al. Mortality Trends of Oncology and Hematopoietic Stem Cell Transplant Patients Supported on Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis. J Intensive Care Med 2022; 37:555.</a></li><li><a class="nounderline abstract_t">Schmidt M, Zogheib E, Rozé H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 2013; 39:1704.</a></li><li><a class="nounderline abstract_t">Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med 2014; 189:1374.</a></li><li><a class="nounderline abstract_t">Pappalardo F, Pieri M, Greco T, et al. Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med 2013; 39:275.</a></li><li><a class="nounderline abstract_t">Roch A, Hraiech S, Masson E, et al. Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center. Intensive Care Med 2014; 40:74.</a></li><li><a class="nounderline abstract_t">Enger T, Philipp A, Videm V, et al. Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study. Crit Care 2014; 18:R67.</a></li><li><a class="nounderline abstract_t">Wilcox ME, Jaramillo-Rocha V, Hodgson C, et al. Long-Term Quality of Life After Extracorporeal Membrane Oxygenation in ARDS Survivors: Systematic Review and Meta-Analysis. J Intensive Care Med 2020; 35:233.</a></li><li><a class="nounderline abstract_t">Daou M, Lauzon C, Bullen EC, et al. Long-Term Cognitive Outcomes and Sleep in Adults After Extracorporeal Life Support. Crit Care Explor 2021; 3:e0390.</a></li><li><a class="nounderline abstract_t">Sanfilippo F, Ippolito M, Santonocito C, et al. Long-term functional and psychological recovery in a population of acute respiratory distress syndrome patients treated with VV-ECMO and in their caregivers. Minerva Anestesiol 2019; 85:971.</a></li><li><a class="nounderline abstract_t">Oh TK, Park HY, Song IA. Delirium and Long-Term Outcomes among Survivors of Extracorporeal Membrane Oxygenation Therapy: A Nationwide Cohort Study in South Korea. J Intensive Care Med 2022; 37:870.</a></li><li><a class="nounderline abstract_t">Fernando SM, Scott M, Talarico R, et al. Association of Extracorporeal Membrane Oxygenation With New Mental Health Diagnoses in Adult Survivors of Critical Illness. JAMA 2022; 328:1827.</a></li><li><a class="nounderline abstract_t">Hodgson CL, Higgins AM, Bailey MJ, et al. Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study. Lancet Respir Med 2022; 10:1038.</a></li><li class="breakAll">University of Leicester. Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock (EUROSHOCK). Available at: http://clinicaltrials.gov/ct2/show/NCT03813134 (Accessed on June 18 2021).</li><li class="breakAll">Extracorporeal Life Support Organization (ELSO). Available at: https://www.elso.org.</li><li class="breakAll">International ECMO Network. Available at: https://www.internationalecmonetwork.org.</li></ol></div><div id="topicVersionRevision">Topic 1625 Version 62.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31408142" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19762075" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29791822" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33197396" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29614239" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support. A Position Paper of the Extracorporeal Life Support Organization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19344471" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11511947" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23291732" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23291732" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26116481" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Acute Respiratory Distress Syndrome With and Without Extracorporeal Membrane Oxygenation: A Score Matched Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32654712" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : COUNTERPOINT: Should Patients With Advanced Lung Disease Be Offered Extracorporeal Membrane Oxygenation as a Bridge to Transplant If They Have Not Yet Been Listed for Lung Transplant? No.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29128016" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Extracorporeal Life Support in Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32654711" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : POINT: Should Patients With Advanced Lung Disease Be Offered Extracorporeal Membrane Oxygenation as a Bridge to Transplant If They Have Not Yet Been Listed for Lung Transplant? Yes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25085497" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24687709" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31677684" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Ethical Considerations for Mechanical Support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33450202" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32807189" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : ECMO during the COVID-19 pandemic: when is it unjustified?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25695688" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29450594" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Position paper for the organization of ECMO programs for cardiac failure in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25062496" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30655061" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A decade of interfacility extracorporeal membrane oxygenation transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26160033" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The Stockholm experience: interhospital transports on extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25149055" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Two decades' experience with interfacility transport on extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25149055" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Two decades' experience with interfacility transport on extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27984321" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Extracorporeal Life Support Organization Registry International Report 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27984321" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Extracorporeal Life Support Organization Registry International Report 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32828186" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32828186" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35191923" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26033984" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29715710" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32171614" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : 30-Day Outcomes Post Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO) After Cardiac Surgery and Predictors of Survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33797800" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Extracorporeal cardiopulmonary resuscitation (ECPR) survival: A quaternary center analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33797800" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Extracorporeal cardiopulmonary resuscitation (ECPR) survival: A quaternary center analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33349100" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Outcomes of Multiple Runs of Extracorporeal Membrane Oxygenation: An analysis of the Extracorporeal Life Support Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34396806" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Mortality Trends of Oncology and Hematopoietic Stem Cell Transplant Patients Supported on Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23907497" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24693864" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23160769" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24170143" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24716510" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29050526" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Long-Term Quality of Life After Extracorporeal Membrane Oxygenation in ARDS Survivors: Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33834171" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Long-Term Cognitive Outcomes and Sleep in Adults After Extracorporeal Life Support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30665282" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Long-term functional and psychological recovery in a population of acute respiratory distress syndrome patients treated with VV-ECMO and in their caregivers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34565204" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Delirium and Long-Term Outcomes among Survivors of Extracorporeal Membrane Oxygenation Therapy: A Nationwide Cohort Study in South Korea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36286084" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Association of Extracorporeal Membrane Oxygenation With New Mental Health Diagnoses in Adult Survivors of Critical Illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36174613" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
